Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A6

    
• • ·Information for Readers

    Page :A8

    

• Editorials

  • ·Regionalization of ST-segment elevation myocardial infarction care: A task unfinished

    Page :633-635

    Akshay Bagai, Christopher B. Granger

    Plan Plan
  • ·Prognostic implications of troponin T and creatine kinase–MB elevation after coronary artery bypass grafting

    Page :636-637

    Michael J. Domanski

    

• Trial Design

  • ·Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: Rationale and design

    Page :638-645

    William T. Abraham, Inder Anand, Juan M. Aranda, John Boehmer, Maria Rosa Costanzo, Teresa DeMarco, Richard Holcomb, Russell Ivanhoe, Michael Kolber, Barry Rayburn

    Résumé Résumé Plan Plan  
  • ·The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

    Page :646

    Chiara Melloni, Dennis L. Sprecher, Lea Sarov-Blat, Manesh R. Patel, John F. Heitner, Christian W. Hamm, Philip Aylward, Jean-Francois Tanguay, Robbert J. DeWinter, Michael S. Marber, Amir Lerman, Vic Hasselblad, Christopher B. Granger, L. Kristin Newby

    Résumé Résumé Plan Plan  
  • ·ABSORB II randomized controlled trial : A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

    Page :654-663

    Roberto Diletti, Patrick W. Serruys, Vasim Farooq, Krishnankutty Sudhir, Cecile Dorange, Karine Miquel-Hebert, Susan Veldhof, Richard Rapoza, Yoshinobu Onuma, Hector M. Garcia-Garcia, Bernard Chevalier

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·Cardiac conduction system disease after transcatheter aortic valve replacement

    Page :664-671

    Benjamin A. Steinberg, J. Kevin Harrison, Camille Frazier-Mills, G. Chad Hughes, Jonathan P. Piccini

    Résumé Résumé Plan Plan  

• Progress in Cardiology

  • ·Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects

    Page :672-680

    Robert S. Rosenson, R. Scott Wright, Michael Farkouh, Jorge Plutzky

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·De Facto regionalization of care for ST-elevation myocardial infarction in Florida, 2001–2009

    Page :681-688

    Colin J. Forsyth, Elizabeth Barnett Pathak, Joel A. Strom

    Résumé Résumé Plan Plan  
  • ·Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI

    Page :689

    Thomas J. Povsic, Douglas W. Losordo, Kenneth Story, Candice E. Junge, Richard A. Schatz, Robert A. Harrington, Timothy D. Henry

    Résumé Résumé Plan Plan  
  • ·Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department

    Page :698

    Jeanette Normann, Matthias Mueller, Moritz Biener, Mehrshad Vafaie, Hugo A. Katus, Evangelos Giannitsis

    Résumé Résumé Plan Plan  
  • ·Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction

    Page :706-714

    Ingo Eitel, Volker Adams, Patrick Dieterich, Georg Fuernau, Suzanne de Waha, Steffen Desch, Gerhard Schuler, Holger Thiele

    Résumé Résumé Plan Plan  
  • ·Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials

    Page :715

    Dengfeng Gao, Ning Ning, Xiaolin Niu, Yinhu Dang, Xin Dong, Jin Wei, Canzhan Zhu

    Résumé Résumé Plan Plan  
  • ·Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

    Page :728-734

    Axel Åkerblom, Lars Wallentin, Agneta Siegbahn, Richard C. Becker, Andrzej Budaj, Jay Horrow, Steen Husted, Hugo Katus, Marc J. Claeys, Robert F. Storey, Nils Åsenblad, Stefan K. James

    Résumé Résumé Plan Plan
  • ·Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy

    Page :735-741

    William T. Abraham, Angel R. León, Martin G. St. John Sutton, Steven J. Keteyian, Ann M. Fieberg, Ed Chinchoy, Garrie Haas

    Résumé Résumé Plan Plan  
  • ·The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

    Page :742

    Suzan Willemsen, Jasper W.L. Hartog, Dirk J. van Veldhuisen, Peter van der Meer, Joline F. Roze, Tiny Jaarsma, Casper Schalkwijk, Iwan C.C. van der Horst, Hans L. Hillege, Adriaan A. Voors

    Résumé Résumé Plan Plan  
  • ·Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications

    Page :750

    Brett D. Atwater, David Dai, Nancy M. Allen-Lapointe, Sana M. Al-Khatib, Louise O. Zimmer, Gillian D. Sanders, Eric D. Peterson

    Résumé Résumé Plan Plan
  • ·Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure

    Page :756-762

    Carlos Rodríguez-Pascual, Arturo Vilches-Moraga, Emilio Paredes-Galán, Ana Isabel Ferrero-Marinez, Marta Torrente-Carballido, Fernando Rodríguez-Artalejo

    Résumé Résumé Plan Plan
  • ·Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

    Page :763

    Kalkidan Bishu, Anita Deswal, Horng H. Chen, Martin M. LeWinter, Gregory D. Lewis, Marc J. Semigran, Barry A. Borlaug, Steven McNulty, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield

    Résumé Résumé Plan Plan  
  • ·Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison

    Page :771-778

    Sander F. Rodrigo, Jan van Ramshorst, Saskia L. Beeres, Imad Al Younis, Petra Dibbets-Schneider, Albert de Roos, Willem E. Fibbe, Jaap J. Zwaginga, Martin J. Schalij, Jeroen J. Bax, Douwe E. Atsma

    Résumé Résumé Plan Plan  
  • ·Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery

    Page :779-785

    Camilla Lund Søraas, Charlotte Friis, Kristin Victoria Tunheim Engebretsen, Leiv Sandvik, Sverre Erik Kjeldsen, Theis Tønnessen

    Résumé Résumé Plan Plan  
  • ·Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

    Page :786-792

    Søren Lindberg, Sune H. Pedersen, Rasmus Mogelvang, Søren Galatius, Allan Flyvbjerg, Jan Skov Jensen, Mette Bjerre

    Résumé Résumé Plan Plan  
  • ·Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

    Page :793

    Anju Bhardwaj, Shafiq U. Rehman, Asim A. Mohammed, Hanna K. Gaggin, Linda Barajas, Justine Barajas, Stephanie A. Moore, Dorothy Sullivan, James L. Januzzi

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Clarification of the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment (REMIT) Trial Protocol

    Page :e15

    Brett D. Thombs

    
  • ·Response to the “Clarification of the REMIT Trial Protocol”

    Page :e17

    Wei Jiang, Maragatha Kuchibhatla, Christopher O'Connor